Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 93,788

Document Document Title
WO/2016/077720A1
The technology relates to monoclonal antibodies useful in detecting and / or treating cancer. In some embodiments, binding agents with specificity for at least one tumor antigen and T cell receptors (e.g., human CD3) are provided. In som...  
WO/2016/075687A2
The present invention provides attenuated or inactivated pathogenic bacteria having anti-cancer properties, compositions comprising the bacteria, and use thereof for treating cancers of the urogenital system.  
WO/2016/076282A1
The present invention develops and provides a technique for reducing environmental impact and saccharifying a plant biomass, especially a lignocellulosic biomass, efficiently in fewer steps in order to efficiently and effectively take ad...  
WO/2016/075687A3
The present invention provides attenuated or inactivated pathogenic bacteria having anti-cancer properties, compositions comprising the bacteria, and use thereof for treating cancers of the urogenital system.  
WO/2016/075314A1
The invention relates to novel transcription factors in oleaginous yeast, in particular Yarrowia lipolytica, as well as to expression cassettes that allow overexpression of said transcription factors. The invention also relates to the us...  
WO/2016/073739A1
The present invention is directed to methods and materials for producing recombinant viruses. In particular, methods and materials are provided for producing recombinant viruses in eukaryotic microalgae such as Chlamydomonas reinhardtii....  
WO/2016/073079A3
Methods and strategies for introducing genetic safeguards into microorganisms, genetically modified organisms (GMO) including the safeguards, and methods of use thereof are provided. The genetic safeguards generally impart a low escape f...  
WO/2016/073079A2
Methods and strategies for introducing genetic safeguards into microorganisms, genetically modified organisms (GMO) including the safeguards, and methods of use thereof are provided. The genetic safeguards generally impart a low escape f...  
WO/2016/072655A1
The cassia seed lactic acid bacteria fermented product of the present invention has been used for a long time and thus is highly safe; is a herb medicine having low possibility of causing side effects; and exhibits an effect of increasin...  
WO/2016/070258A1
The present invention provides technical solutions for the production of second generation fuels based on plant biomass conversion, for example from cell wall polymers. The present invention describes, inter alia, a genetically modified ...  
WO/2016/071570A1
The present description is related to the field of cultivating algae. It introduces a method of cultivating algae by depleting the culture of an inorganic nutrient and exposing the alga to high intensity light to obtain algal cell mass h...  
WO/2016/073585A1
General secretory pathway (GSP) mutant Listeria bacteria are provided. Aspects of the bacteria include the presence of a GSP mutation, e.g., a SecY and/or SecA mutation. Also provided are methods of making and using the Listeria bacteria...  
WO/2016/072563A1
The present invention provides: a method capable of increasing the production of lipid by culturing diploid microalgae Chlamydomonas sp., obtained by treating haploid wild-type microalgae Chlamydomonas sp. with colcemid; a method for pro...  
WO/2016/070814A1
Provided is a high-stability T cell receptor (TCR). The TCR comprises (i) the whole or a part of TCRα chain except a transmembrane domain thereof, and (ii) the whole or a part of TCRβ chain except a transmembrane domain thereof, both t...  
WO/2016/072448A1
Provided is an endoxylanase mutant having improved thermal stability. An endoxylanase mutant having endoxylanase activity and including an amino acid sequence in which one or more amino acid residues selected from positions corresponding...  
WO/2016/071707A1
The present invention resides in a method for the manufacture of a disulphide- requiring biopharmaceutical having an element of at least tertiary structure using wild type E. coli.  
WO/2016/070849A1
Provided in the present invention are a class of Lincomycin biosynthetic intermediates and a preparation method and use thereof. Specifically provided are Lincomycin biosynthetic intermediates obtained from the genetic modification of a ...  
WO/2016/073353A1
Embodiments disclose an apparatus and methods for biological sample processing enabling isolation and enrichment of microbial or pathogenic constituents from the sample. A vessel for sample containment and extraction is further disclosed...  
WO/2016/073364A1
A method and immunogenic composition for blocking transmission of a Plasmodium species via an Anopheles species. The immunogenic composition, containing a Fibrinogen-Related Protein 1 (FREP1) protein and/or an immunogenic portion thereof...  
WO/2016/069345A1
The invention generally provides a sample preparation vessel including a flexible substrate defining at least one sealable opening adapted and configured to receive a solid sample; at least one fitting; and at least one filter adjacent t...  
WO/2016/068266A1
The present invention provides a cell culture substrate which includes a nanofiber, made of a biodegradable polymer, on a support made of a biodegradable polymer. Further, provided is a cell culture method which is characterized by perfo...  
WO/2016/070160A1
The invention provides methods and systems for the production of lipid products from a gaseous substrate using a two stage fermentation process. The method comprises providing a gaseous substrate comprising CO, CO2 or H2 or mixtures ther...  
WO/2016/066260A1
The present invention provides methods for the non-covalent surface display of proteins of interest (POI), in particular for Fc-domain containing proteins such as antibodies. The inventive method may be used to screen and select proteins...  
WO/2016/065698A1
Provided are a saccharomyces cerevisiae strain CCTCC M 2014463 capable of being co-fermented by multiple carbon sources and an application thereof. The strain can adopt glucose, galactose, xylose, allulose, cane sugar, maltose, melibiose...  
WO/2016/068249A1
A cell isolation method comprises: a cell trapping step of allowing a solution of interest to pass through a cell trapping filter having multiple through-holes formed therein as observed in the thickness direction, thereby trapping isola...  
WO/2016/069432A1
The present invention relates to isolated or purified asporogenous Bacillus megaterium (B. megaterium) strains comprising a B. megaterium genome, wherein said genome is modified in that the spo0A gene is deleted or functionally deleted a...  
WO/2016/068612A1
The present invention relates to a food composition for alleviating a hangover, the composition containing, as an active ingredient, at least one strain selected from Lactococcus chungangensis, Lactococcus fujiensis, Lactococcus lactis s...  
WO/2016/069888A1
Compositions and uses involving L. monocytogenes PssZ, as well as homologs, variants, and fragments thereof, are described.  
WO/2016/070151A8
The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. Specifically, the disclosure provides methods for treatment of metabolic cond...  
WO/2016/066690A1
The present invention relates to mutant filamentous fungal host cells producing a polypeptide of interest, wherein two or more polynucleotides encoding two or more polypeptides involved in alpha-glucan synthesis are inactivated; methods ...  
WO/2016/065709A1
Disclosed are the construction method and application of metabolically engineered E. coli strains for producing succinic acid by using acetic acid, wherein succinic acid is produced from the metabolically engineered modified E. coli by f...  
WO/2016/070174A1
The present invention provides compositions and methods of reducing cyanuric acid levels in recreational water systems.  
WO/2016/068270A1
The objective of the present invention is to provide a ligand-binding fiber formed by immobilizing a ligand having an affinity with a cell membrane receptor on a fiber precursor, and to provide, using said ligand-binding fiber, a cell cu...  
WO/2016/065453A1
The present invention describes an expression cassette for eukaryotic cell transformation, comprising the nucleotide sequence (SEQ ID NO: 2) encoding a xylose isomerase peptide (SEQ ID NO: 1), optionally also comprising other genes of th...  
WO/2016/070151A1
The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. Specifically, the disclosure provides methods for treatment of metabolic cond...  
WO/2016/065470A1
A microfluidic device, method and kit for assaying and/or culturing cells are provided. The microfluidic device comprises a well block comprising a plurality of microwells; at least one cell culture layer selected from a first cell cultu...  
WO/2016/068427A1
The present invention relates to an interleukin-2 expression construct for yeast and yeast containing same, the expression construct comprising: a methanol oxidase promoter; human serum albumin (HSA) or a fragment gene thereof; and an in...  
WO/2016/069155A2
The present disclosure provides methods for biosynthesis of acetaminophen. The present disclosure provides host cells genetically modified to provide for production of acetaminophen.  
WO/2016/066896A1
The invention relates to novel variants of fungal endoglucanases, their production and means for their production. Especially the invention relates to variants of Acremonium thermophilum Cel45A. The invention further relates to enzyme pr...  
WO/2016/068093A1
Provided is Frateribacillus flavoalbus, which is a novel species of Frateribacillus and includes the following properties: 1) the microorganism is gram-negative and forms spores; 2) the microorganism is oxidase-negative, catalase-positiv...  
WO/2016/068428A1
The present invention relates to a method for producing an interleukin-2 protein using methylotrophic yeast. The method for producing interleukin-2 of the present invention shows a high growth and protein synthesis rate by establishing a...  
WO/2016/068218A1
The present invention addresses the problem of providing a novel enzyme that exhibits a cholesterol dehydrogenase activity. Provided is a mutated enzyme that comprises an amino acid sequence derived from the amino acid sequence of a micr...  
WO/2016/063637A1
Provided is a method for screening a compound, said compound being capable of specifically inhibiting the formation of caveolae in cancer cells and comprehensively inhibiting various RTK activities only by the single compound. A screenin...  
WO/2016/062771A1
The invention relates to products and compositions that may be beneficial in animal husbandry. Said products and compositions comprise microorganisms, such as bacteria, and probiotic bacteria in particular. Thus, provided herein are micr...  
WO/2016/061827A1
The present invention relates to a biological degumming method for ramie. The method comprises the following steps: using bacillus (Bacillus sp. HG-28) as a strain; obtaining a degumming bacteria solution F used for biological degumming ...  
WO/2016/065341A1
Delivering a payload across a plasma membrane of a cell includes providing a population of cells and contacting the population of cells with a volume of an aqueous solution. The aqueous solution includes the payload and alcohol content g...  
WO/2016/064146A1
The present invention relates to a composition for preparing tagatose, wherein the composition is used for preparing tagatose from fructose and contains a protein including any one amino acid sequence of SEQ ID NOS: 1 to 7 or a strain ex...  
WO/2016/064000A1
The present invention relates to Lactobacillus plantarum Probio 090 having antiviral and antipathogenic bacterial activities and, more specifically, provides: Lactobacillus plantarum Probio 090 for inhibiting the activity of viruses and ...  
WO/2016/065085A1
Apparatuses and associated methods are described for the efficient evaluation of C1-containing substrates, and especially for such evaluation conducted locally, or on-site, at a prospective facility for implementation of a biological con...  
WO/2016/063516A1
Provided is an organism and substance manufacturing method that enables appropriate control of organism proliferation and substance production. The organism has equipped in DNA: a proliferation participating region that relates to organi...  

Matches 401 - 450 out of 93,788